K V Pharmaceutical Co. Class A (NYSE:KV-A)

CAPS Rating: 2 out of 5

Develops advanced drug delivery technologies which enhance the effectiveness of new therapeutic agents, existing pharmaceutical products and prescription nutritional products.

Recs

0
Player Avatar Stockpwner (< 20) Submitted: 8/1/2011 5:13:07 PM : Underperform Start Price: $2.05 KV-A Score: +38.97

Sell

Report this Post Reply

Featured Broker Partners


Advertisement